drugset / Trial / NCT01943487

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

NCT01943487

Phase 1 Completed 36 enrolled Astellas Pharma Europe B.V.
NaSingle-groupOpen-labelBasic science

Summary

This study investigates the effect of the co-administration of verapamil on the steady-state pharmacokinetics (PK) of solifenacin succinate and tamsulosin given as a combination tablet, EC905.

Timeline

Start
2009-08
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule Oral
Subject Tamsulosin Other / unclassified Oral
Subject Verapamil Other / unclassified Oral

Indications

No indication recorded.